|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
THE STEM CELL NICHE |
1 Stem Cell Institute at the James Graham Brown Cancer Center, University of Louisville, Louisville, USA
2 Tumor Immunobiology Program, University of Louisville, Louisville, USA
3 Case Western University, Cleveland, OH
4 Department of Medicine, University of Alberta and CBS Edmonton, Alberta, Canada
5 Stem Cell Institute at the James Graham Brown Cancer Center, University of Louisville, Louisville, USA; Department of Physiopathology, Pomeranian Medical University, Szczecin, Poland.
* To whom correspondence should be addressed. E-mail: mzrata01{at}louisville.edu.
| Abstract |
|---|
Complement (C) and innate immunity emerge as important and underappreciated modulators of mobilization of hematopoietic stem/progenitor cells (HSPC). We reported that i) C becomes activated in bone marrow (BM) during G-CSF-induced mobilization by the classical immunoglobulin (Ig)-dependent pathway, and that ii) C3 cleavage fragments increase the responsiveness of HSPC to an SDF-1 gradient. Since patients suffering from severe combined immunodeficiency (SCID) mobilize poorly, we hypothesized that this could be directly linked to the lack of C activating Ig in these patients. In the current study to better elucidate the role of C activation in HSPC mobilization, we mobilized mice that lack Ig (RAG2, SCID and Jh) by G-CSF or zymosan, compounds that that activate C by the classical Ig-dependent and the alternative Ig-independent pathways, respectively. In addition we evaluated mobilization in C5-deficient animals. Mobilization was evaluated by measuring the number of CFU-GM and leukocytes circulating in peripheral blood. We found that i) G-CSF- but not zymosan-induced mobilization, was severely reduced in RAG2, SCID and Jh mice, ii) impaired G-CSF-induced mobilization was restored after infusion of purified wild type Ig, and iii) mobilization was severely reduced in C5-deficient mice. These data provide strong evidence that the C system plays a pivotal role in mobilization of HSPC and that egress of HSPC from BM occurs as part of an immune response.
Key Words. Complement, C3, C5, mobilization, G-CSF, zymosan, CXCR4
This article has been cited by other articles:
![]() |
D. E. Cramer, S. Wagner, B. Li, J. Liu, R. Hansen, R. Reca, W. Wu, E. Z. Surma, D. A. Laber, M. Z. Ratajczak, et al. Mobilization of Hematopoietic Progenitor Cells by Yeast-Derived {beta}-Glucan Requires Activation of Matrix Metalloproteinase-9 Stem Cells, May 1, 2008; 26(5): 1231 - 1240. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
